1. Home
  2. YEXT vs NBTX Comparison

YEXT vs NBTX Comparison

Compare YEXT & NBTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Yext Inc.

YEXT

Yext Inc.

HOLD

Current Price

$8.10

Market Cap

1.0B

Sector

Technology

ML Signal

HOLD

Logo Nanobiotix S.A.

NBTX

Nanobiotix S.A.

HOLD

Current Price

$23.04

Market Cap

1.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
YEXT
NBTX
Founded
2006
2003
Country
United States
France
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.0B
1.0B
IPO Year
2017
2020

Fundamental Metrics

Financial Performance
Metric
YEXT
NBTX
Price
$8.10
$23.04
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
4
1
Target Price
$9.44
$8.00
AVG Volume (30 Days)
1.0M
37.8K
Earning Date
12-08-2025
09-30-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.00
N/A
Revenue
$447,666,000.00
$11,930,711.00
Revenue This Year
$8.66
N/A
Revenue Next Year
$4.77
$145.24
P/E Ratio
$13,993.17
N/A
Revenue Growth
9.46
N/A
52 Week Low
$5.51
$2.82
52 Week High
$9.20
$30.35

Technical Indicators

Market Signals
Indicator
YEXT
NBTX
Relative Strength Index (RSI) 36.25 58.15
Support Level $8.30 $21.44
Resistance Level $8.61 $24.01
Average True Range (ATR) 0.20 0.87
MACD -0.04 0.07
Stochastic Oscillator 6.62 73.94

Price Performance

Historical Comparison
YEXT
NBTX

About YEXT Yext Inc.

Yext Inc provides a knowledge engine platform that lets businesses manage their digital knowledge in the cloud and sync it to approximately 200 services including Apple Maps, Bing, Cortana, Facebook, Google, Google Maps, Instagram, Siri and Yelp. Digital knowledge is the structured information that a business wants to make publicly accessible. The company also makes search intelligent by helping to provide precise, accurate and current answers to location-based queries that are conducted across the web and mobile applications and voice and artificial intelligence, or AI, engines. The company derives the majority of its revenues from subscription services. Geographically, the company generates a majority of its revenue from North America and the rest from International markets.

About NBTX Nanobiotix S.A.

Nanobiotix SA is a clinical-stage biotechnology company that has one operating segment, which focuses on developing product candidates that use its proprietary nanotechnology to transform cancer treatment by increasing the efficacy of radiotherapy. The company develops NanoXray products to help patients receiving radiotherapy by magnifying the effect of radiotherapy within tumor cells without increasing the dose to surrounding healthy tissues. Its product candidate is NBTXR3, a preclinical research program for cancer immunotherapies.

Share on Social Networks: